Pharmaceutical ETFs Break Out on Horizon Pharma’s Positive Drug Results
February 28, 2019 at 16:43 PM EST
Pharmaceutical sector-related ETFs stood out Thursday after Horizon Pharma (HZNP) revealed positive test results for its treatment of thyroid eye disease, or TED. Among the better performing non-leveraged ETFs of Thursday, the First Trust Nasdaq Pharmaceuticals ETF (NasdaqGM: FTXH) rose 1.8%,...
